Last Patient Enrolled for the Phase II Clinical Trial of Zhaoke Ophthalmology’s ZKY001, for the Treatment of Corneal Epithelial Defects

Zhaoke Ophthalmology Received the “Most Valuable Pharmaceutical and Medical Company” Award From Zhitong Finance’s Sixth Golden Hong Kong Stocks Award

Zhaoke Ophthalmology Partners with Yidu Tech’s HappyLife Tech to Accelerate the Development of Innovative Clinical Research for the Chinese Ophthalmic Market

Zhaoke Ophthalmology Selected as a Presenting Company at the Eyecelerator@AAO 2021 Conference

Podcast Series Episode 5: Transforming the Visual Health of Young People in China